Fidson Healthcare Plc. was incorporated in March 1995 and has grown to become the leading pharmaceutical company in Nigeria.
Though it started as a local distributor of pharmaceutical products, the company has relentlessly pursued its goal to become the leading player in the pharmaceutical and Healthcare ecosystem in West Africa. Our core values – Innovation, Excellence, Passion, Integrity, and Ownership – form the backbone on which we have built a world-class company that has earned the respect and admiration of even the fiercest of our competitors.
Barely a year into its existence, Fidson started the importation of its own brands of finished medicines – introducing Ciprotab and Peflotab brands of quinolones to the market. By July 2002, Fidson set up its first local manufacturing facility and later became the first company in sub-Saharan Africa to manufacture Antiretroviral (ARV) drugs in March 2005.
Expanding its business even further, Fidson was listed on the floor of the Nigerian Stock Exchange, (NSE) to become a publicly quoted company in 2008 and completed its 3rd Factory in the same year. About a year later, the company won the Financial Standard Sector Leader Award.
With a Market Capitalization of 36.5 billion Naira, Fidson has become the largest pharmaceutical company in the healthcare sector of the NSE. The company reported a turnover of ₦53.05billion for the year ended 31 December 2023.
Today, we manufacture ten (10) distinct dosage forms from our ultramodern, World Health Organisation Current Good Manufacturing Practice (WHO cGMP) certifiable factory in Ota, Ogun State and are a distinguished candidate for pre-qualification by WHO.
By leveraging our relationships and collaborations with various international technical partners – most of whom are market leaders in their areas of specializations – we can deliver high-quality medicines to Africa. Today, we offer over 350 NAFDAC registered brands including POMs & OTCs across various therapeutic classes and pharmacological segments. We also provide excellent services including research, formulation & development, and contract manufacturing.
Fidson prides itself in quality and technical excellence and had received the NIS ISO 9001:2000 certification for Quality Management Systems from the Standards Organization of Nigeria (SON) in November 2017. This has subsequently been upgraded to NIS ISO 9001:2015. Also, in 2019, we received the NIS ISO 14001: 2015 certification for our excellent Environmental Management Systems and still retained the certification following the successful recertification audit conducted in December 2021 that conferred compliant status of the company in accordance with current management system requirements. We are the only company in our sector to achieve this feat. We are currently the sole manufacturing partner for GSK and Bayer in Nigeria.